TrialJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association2022

Use of cyproheptadine hydrochloride (HCl) to reduce neuromuscular hypertonicity in stroke survivors: A Randomized Trial: Reducing Hypertonicity in Stroke.

Derek Kamper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.